Esperion Therapeutics
ESPR
ESPR
164 hedge funds and large institutions have $458M invested in Esperion Therapeutics in 2022 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 57 increasing their positions, 39 reducing their positions, and 26 closing their positions.
Holders
164
Holders Change
+16
Holders Change %
+10.81%
% of All Funds
2.65%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
44
Increased
57
Reduced
39
Closed
26
Calls
$50.2M
Puts
$14.2M
Net Calls
+$36M
Net Calls Change
+$17.6M
Top Buyers
1 |
1
Balyasny Asset Management
Chicago,
Illinois
|
$21.4M |
2 |
2
Citadel Advisors
Miami,
Florida
|
$9.66M |
3 |
3
BlackRock
New York
|
$34.3M |
4 |
JFG
4
Jefferies Financial Group
New York
|
$5.64M |
5 |
ECM
5
ExodusPoint Capital Management
New York
|
$7.3M |